Status:
UNKNOWN
Disease Course in Oncological Patients During Inpatient Rehabilitation and After Three Months Follow-up
Lead Sponsor:
Klinik Valens
Conditions:
Oncologic Disorders
Eligibility:
All Genders
18+ years
Brief Summary
Constant improvements in the areas of diagnostics and treatment lead to an increase of patients surviving an oncological diagnosis ("cancer survivors") thus increasing the cost factor on both society ...
Eligibility Criteria
Inclusion
- Diagnosed with "Cancer";
- Literacy and understanding German language;
- Signed informed consent;
Exclusion
- Women who are pregnant or breastfeeding / have the intention to become pregnant during the course of the study;
- Other clinically significant concomitant disease states (e.g. renal failure, hepatic dysfunction, cardiovascular disease, etc);
- Known or suspected non-compliance, drug or alcohol abuse;
- Inability to follow the procedures of the study: e.g. due to language problems, psychological disorders, dementia of the participant, etc;
- Enrolment of the investigator, his/her family members, employees and other dependent persons;
- Cognitive impairment: Mini-Mental State Examination (MMSE) \< 21;
- Major Depression or Hospital Anxiety and Depression Scale (HADS) \>11 at baseline.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04842214
Start Date
January 1 2019
End Date
December 30 2023
Last Update
September 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kliniken-Valens
Valens, Canton of St. Gallen, Switzerland, 7317